RESUMEN
In developing nations such as Indonesia, obesity and central obesity have emerged as major public health issues. Many studies have revealed that morbidity and death from obesity-related diseases are already significant in some "Asian" communities at low body mass index (BMI) levels. A recent study showed that the obesity prevalence in Indonesia is underestimated when using the current BMI cutoff (obeseâ ≥â 27.0). Indonesia faced an increase in obesity-related chronic diseases despite having a lower obesity prevalence than developed countries, which may be explained by the underestimation of obesity levels in Indonesia. This creates a huge global health problem, as well as an economic burden. Another recent study on the Indonesian population depicted the new proposed cutoff of waist circumference (WC), which is lower than the World Health Organization (WHO) standard for detecting the early detection of type 2 diabetes mellitus (T2DM), one of the comorbidities and a strong correlation with obesity. An analysis of 58 studies in 2021 that included Indonesian adult subjects revealed enormous differences and ambiguities in defining obesity cutoffs values among Indonesian researchers. Additionally, we advocate adding the Edmonton Obesity Staging System (EOSS) staging to the anthropometric classification for a better clinical evaluation of obesity. Considering the urgency of obesity determination in Indonesia for clinical application and study purposes, this review highlights the need to revise the optimal cutoff value for obesity to warrant early prevention and control of diabetes complications.
Asunto(s)
Diabetes Mellitus Tipo 2 , Adulto , Humanos , Indonesia/epidemiología , Diabetes Mellitus Tipo 2/epidemiología , Diabetes Mellitus Tipo 2/complicaciones , Obesidad/complicaciones , Índice de Masa Corporal , Obesidad Abdominal/epidemiología , Circunferencia de la Cintura , Factores de RiesgoRESUMEN
The pandemic of COVID-19 has been a game changer in many aspects of medical care, including laparoscopic surgery service. Uncertainty in the early pandemic has led to the fear of doing laparoscopic surgery with regard to the possibility of SARS-COV-2 transmission through surgical smoke. We carried out laparoscopic surgery during the COVID-19 pandemic with intention to test our local adaptation of a laparoscopic smoke evacuator. Twenty-five laparoscopic cases for digestive surgery were performed with uneventful results. In summary, a low cost local adaptation of laparoscopic smoke and safe surgical behavior should be the standard of care when delivering laparoscopic surgery service in the pandemic era and forward.
Asunto(s)
COVID-19 , Transmisión de Enfermedad Infecciosa de Paciente a Profesional/prevención & control , Laparoscopía/métodos , Laparotomía/métodos , Humo/efectos adversos , Ventilación/métodos , Humanos , Control de Infecciones/métodos , Pandemias , SARS-CoV-2RESUMEN
INTRODUCTION: The Asia-Pacific Metabolic and Bariatric Surgery Society (APMBSS) held its congress in Tokyo at the end of March, 2018, and representatives from Asia-Pacific countries presented the current status of bariatric/metabolic surgery in the "National Reports" session. The data are summarized here to show the current status and problems in the Asia-Pacific region in 2017. METHODS: A questionnaire including data of 2016 and 2017 and consisting of eight general questions was prepared and sent to representatives in 18 Asia-Pacific countries by e-mail before the congress. After the congress, the data were analyzed and summarized. RESULTS: Seventeen of 18 countries responded to the survey. The frequency of obesity (BMI ≥ 30) in the 4 Gulf countries was > 30%, much higher than that in the other countries. In total, 1640 surgeons and 869 institutions were engaging in bariatric/metabolic surgery. In many East and Southeast Asian countries, the indication for bariatric surgery was BMI ≥ 35 or ≥ 37, whereas in many Gulf countries and Australia, it was BMI ≥ 40 or ≥ 35 with obesity-related disease. Ten of the 17 countries (58.8%) but only one of the 5 Southeast Asian countries (20.0%) had public health insurance coverage for bariatric surgery. In 2017, 95,125 patients underwent bariatric/metabolic surgery, with sleeve gastrectomy accounting for 68.0%, bypass surgery for 19.5%, and others for 12.5%. Current problems included public insurance coverage, training system, national registry, and lack of awareness and comprehension. CONCLUSION: This summary showed that bariatric/metabolic surgery is rapidly developing along with various problems in Asia-Pacific countries.
Asunto(s)
Cirugía Bariátrica/estadística & datos numéricos , Diabetes Mellitus/epidemiología , Diabetes Mellitus/cirugía , Obesidad/epidemiología , Obesidad/cirugía , Adulto , Asia/epidemiología , Australia/epidemiología , Cirugía Bariátrica/economía , Cirugía Bariátrica/métodos , Correo Electrónico , Femenino , Encuestas de Atención de la Salud , Humanos , Masculino , Persona de Mediana Edad , Programas Nacionales de Salud , Obesidad/complicacionesRESUMEN
Minimally invasive surgery is designed to provide a friendlier surgical therapy, in terms of faster recovery times, improved cosmetic results, and reduced postoperative pain. In recent years, a new genre for exploring the abdominal cavity without incisions has been developed. Incisionless surgery is considered the next frontier in minimally invasive surgery. The idea is to use natural orifices as the entry point to the abdomen, by using an endoscope through a transgastric, transvaginal, transvesical, or transcolonic access; hence, it is called as natural orifice transluminal endoscopic surgery (NOTES). We report our first case of laparoscopic-assisted transvaginal cholecystectomy. We support that NOTES can provide benefits in terms of reduced pain, faster recovery, and better cosmetic results compared with conventional laparoscopic surgery.